AMEX · RXL
Financial Services · Asset Management
$59.87
Down-$0.38 (-0.63%)
Updated Sep 25, 2026, 2:56 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
RXL closed at $59.87 after 20 trading sessions, down 1.87% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $60.77 | $60.77 | $59.62 | $59.8667 | 5.64K |
| Sep 23, 2026 | $59.98 | $59.98 | $58.64 | $59.01 | 6.9K |
| Sep 22, 2026 | $58.71 | $60.142 | $58.71 | $59.88 | 5.44K |
| Sep 21, 2026 | $58.42 | $59.3247 | $58.42 | $59.3247 | 3.34K |
| Sep 18, 2026 | $58.57 | $58.57 | $58.085 | $58.36 | 2.95K |
| Sep 17, 2026 | $58.27 | $58.74 | $58.27 | $58.71 | 4.91K |
| Sep 16, 2026 | $58.48 | $58.48 | $57.78 | $57.99 | 8.45K |
| Sep 15, 2026 | $57.21 | $58.02 | $57.21 | $57.8361 | 3.75K |
| Sep 14, 2026 | $57.85 | $58.42 | $57.59 | $57.95 | 14.96K |
| Sep 11, 2026 | $57.20 | $57.20 | $56.38 | $56.431 | 3.94K |
| Sep 10, 2026 | $57.40 | $57.47 | $56.59 | $56.59 | 6.06K |
| Sep 9, 2026 | $57.63 | $57.63 | $57.20 | $57.32 | 12.28K |
| Sep 8, 2026 | $57.79 | $58.525 | $57.5356 | $57.5709 | 9.14K |
| Sep 4, 2026 | $61.04 | $61.259 | $60.6404 | $60.6726 | 5.16K |
| Sep 3, 2026 | $61.081 | $62.18 | $60.95 | $62.02 | 4.63K |
| Sep 2, 2026 | $61.19 | $62.75 | $61.19 | $61.95 | 53.85K |
| Sep 1, 2026 | $61.32 | $62.20 | $60.6601 | $60.8558 | 8.39K |
| Aug 31, 2026 | $60.10 | $60.37 | $59.97 | $60.2649 | 26.37K |
| Aug 28, 2026 | $60.79 | $60.79 | $60.34 | $60.5429 | 118.02K |
| Aug 27, 2026 | $61.135 | $61.43 | $60.9387 | $61.009 | 4.29K |
The latest Smart Investors Daily articles mentioning RXL.
RXL research
Company profile and research snapshot.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is designed to measure the stock performance of U.S. companies in the healthcare industry. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Jun 7, 2024
Rexel : Déclaration relative au nombre total d’actions et de droits de vote au titre de l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers
GlobeNewswire Inc. · Jun 7, 2024
Rexel: Statement relating to the total number of shares and voting rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Rules of the French Autorité des marchés financiers
GlobeNewswire Inc. · Jun 7, 2024
Powering Up Rexel to the next level Update on medium-term roadmap and upgraded financial targets presented at Capital Markets Day
GlobeNewswire Inc. · May 15, 2024
Paris, May 15, 2024
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RXL.
No results
No recent SID articles mention RXL.
